RAPT Therapeutics Inc. (RAPT)
1.22
0.03 (2.52%)
At close: Jan 17, 2025, 3:59 PM
1.20
-1.23%
After-hours Jan 17, 2025, 04:00 PM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| PE Ratio | -8.16 | -7.87 | -14.75 | -9.01 | -14.02 | -6.23 | -6.46 |
| PS Ratio | n/a | 421.94 | 263.85 | 94.54 | n/a | n/a | n/a |
| PB Ratio | 6.48 | 2.63 | 5.40 | 4.58 | 8.24 | 3.52 | -3.01 |
| P/FCF Ratio | -9.7 | -9 | -16.28 | -11.66 | -16.58 | -6.18 | -6.66 |
| P/OCF Ratio | -9.82 | -9.1 | -16.49 | -11.77 | -16.99 | -6.84 | -6.93 |
| OCF/S Ratio | n/a | -46.35 | -16 | -8.03 | n/a | n/a | n/a |
| Debt / Equity Ratio | 0.05 | 0.04 | n/a | n/a | n/a | 2.52 | -1.74 |
| Quick Ratio | 7.41 | 17.77 | 20.11 | 9.84 | 8.70 | 14.01 | 14.85 |
| Current Ratio | 7.41 | 17.77 | 20.11 | 9.84 | 8.70 | 14.01 | 14.85 |
| Asset Turnover | n/a | 0.01 | 0.02 | 0.04 | n/a | n/a | n/a |
| Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Return on Equity (ROE) | -0.79 | -0.33 | -0.37 | -0.51 | -0.59 | -0.56 | 0.47 |
| Return on Assets (ROA) | -0.67 | -0.31 | -0.34 | -0.44 | -0.51 | -0.52 | -0.58 |
| Return on Capital (ROIC) | -0.84 | -0.34 | -0.37 | -0.5 | -0.58 | -0.57 | -0.62 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | n/a | -83.82% | 73.88% | 100.00% | n/a | n/a | n/a |
| Net Profit Margin | n/a | -5.36K% | -1.79K% | -1.05K% | n/a | n/a | n/a |
| Pretax Profit Margin | n/a | -5.49K% | -1.81K% | -1.03K% | n/a | n/a | n/a |
| Operating Profit Margin | n/a | -5.62K% | -1.82K% | -1.06K% | n/a | n/a | n/a |
| FCF Margin | n/a | -4.69K% | -1.62K% | -810.97% | n/a | n/a | n/a |
| EBITDA Margin | n/a | -5.55K% | -1.79K% | -1.03K% | n/a | n/a | n/a |